-The Hindu Union Commerce and Industry Minister Anand Sharma has termed "historic" the Supreme Court's rejection of Novartis' claim for patent for its anti-cancer drug Glivec. He said the Indian Patent Act was in conformity with its international obligations under the Trade Related Aspects of Intellectual Property Rights Agreement. "It is a historic judgment. It reaffirms the position of Indian law and, in particular, provisions of Section 3D, which mandates... a substantive...
More »SEARCH RESULT
The silent war over education reforms-Krishna Kumar
-The Hindu Despite apparent similarities, the reports of two centrally appointed committees are split on the relationship between knowledge, skills and social needs Two major reports with overlapping concerns were submitted to the central government during the last decade. They were drafted by committees appointed by two different offices of the same government. One was chaired by Yash Pal, and the other by Sam Pitroda. The titles of the two committees indicated...
More »SC verdict on Novartis AG plea today
-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...
More »CAG questions costing of 350-acre Gurgaon land sold to DLF -Navneet Sharma
-The Hindustan Times In what seems set to provide fresh ammo to its political rivals, the comptroller and auditor general (CAG) is learnt to have raised questions about the valuation of 350 acres given by the Haryana government to realty major DLF Limited in Gurgaon through competitive bidding for setting up a recreation-cum-leisure project. The CAG, which examined the procedures and the competitive bidding route taken by the Haryana State Industrial and...
More »Patients win over patents-Srividhya Ragavan
-The Hindu Justice Prabha Sridevan’s judgment permitting the production and sale of a generic version of a cancer drug is a victory for patients. It posits the public interest, especially in matters of health care, right at the heart of intellectual property rights in India Monday was a remarkable day for cancer patients in India. To them, the country said — “we care.” I am talking about the astounding decision by Justice...
More »